Still learning, have been trying to edit my post. Probably more...

Still learning, have been trying to edit my post. Probably more relevance to its spin off company elixinol Pty Ltd who are more focused in the med cann space rather then the hemp supplement business. It does tie up two major Australian distributors. I hold exl and think it has great prospects and it does have a head start. This will rapidly become a crowded space though so needs watching closely.  Already canopy growth is making a move in the hemp space in the US, others won’t be far behind.

I am just trying to understand the sudden huge drop today which coincided with both canopy growth announcing its US hemp operations and BOD’s announcement. Wondering if Both are likely  to play on the minds of investors even if not completely justified.